Transformando el futuro de la industria farmacéutica
Email: info@amarintech.com.ar
The use of Quality by Design (QbD) concept to medicated plasters (patches) development gives us the certainty to obtain safety and reliable products for patients with verifiable efficacy, long before they enter their production stage. [...]
In this article, we will examine the evolution, prospects, and current challenges of the generic drug market in the United States. [...]
The pharmaceutical industry significantly impacts the environment due to the generation of hazardous waste, the use of energy and water, and the emission of greenhouse gases. [...]
With the large amount of information found on the internet, it is often difficult for us to differentiate truth from myth or lie. That is why in this article we collect some claims of transdermal patches and if they are true or false. [...]
Cleaning validation is a procedure of establishing evidence that cleaning processes for manufacturing equipment prevent product contamination [...]
In recent years, laboratories have been investigating new alternatives to eliminate or avoid animal testing of cosmetic and medical products. [...]
The correct adhesion of a transdermal patch to skin throughout the established time of use is key to guarantee the effective administration of the dose declared in the prescribing information. [...]
Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, .. [...]
The production of transdermal patches is a continuous and artisanal process that consists of 3 stages that reflect how delicate and specific is the production of this niche pharmaceutical form. Let´s review it! [...]
Far away, in 1979, the first transdermal patch to reach the market, produced under an industrial controlled process and backed by clinical studies, was launched in US under the brand name TransderScop®. [...]